BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 23067421)

  • 1. [G-protein-coupled receptors plasticity and signalling].
    Galés C
    Med Sci (Paris); 2012 Oct; 28(10):883-5. PubMed ID: 23067421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evasive nature of drug efficacy: implications for drug discovery.
    Galandrin S; Oligny-Longpré G; Bouvier M
    Trends Pharmacol Sci; 2007 Aug; 28(8):423-30. PubMed ID: 17659355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Versatility of GPCR recognition by drugs: from biological implications to therapeutic relevance.
    Bosier B; Hermans E
    Trends Pharmacol Sci; 2007 Aug; 28(8):438-46. PubMed ID: 17629964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. When simple agonism is not enough: emerging modalities of GPCR ligands.
    Smith NJ; Bennett KA; Milligan G
    Mol Cell Endocrinol; 2011 Jan; 331(2):241-7. PubMed ID: 20654693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand- and heterodimer-directed signaling of the CB(1) cannabinoid receptor.
    Hudson BD; Hébert TE; Kelly ME
    Mol Pharmacol; 2010 Jan; 77(1):1-9. PubMed ID: 19837905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refining efficacy: exploiting functional selectivity for drug discovery.
    Gesty-Palmer D; Luttrell LM
    Adv Pharmacol; 2011; 62():79-107. PubMed ID: 21907907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of conformational ensembles of seven transmembrane receptors in functional selectivity.
    Vaidehi N; Kenakin T
    Curr Opin Pharmacol; 2010 Dec; 10(6):775-81. PubMed ID: 20933468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging structural insights into biased GPCR signaling.
    Shukla AK; Singh G; Ghosh E
    Trends Biochem Sci; 2014 Dec; 39(12):594-602. PubMed ID: 25458114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilot the pulse: controlling the multiplicity of receptor dynamics.
    Bock A; Kostenis E; Tränkle C; Lohse MJ; Mohr K
    Trends Pharmacol Sci; 2014 Dec; 35(12):630-8. PubMed ID: 25455830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G Protein-coupled Receptor Biased Agonism.
    Hodavance SY; Gareri C; Torok RD; Rockman HA
    J Cardiovasc Pharmacol; 2016 Mar; 67(3):193-202. PubMed ID: 26751266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biased agonism at G protein-coupled receptors: the promise and the challenges--a medicinal chemistry perspective.
    Shonberg J; Lopez L; Scammells PJ; Christopoulos A; Capuano B; Lane JR
    Med Res Rev; 2014 Nov; 34(6):1286-330. PubMed ID: 24796277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel roles for arrestins in G protein-coupled receptor biology and drug discovery.
    Claing A; Laporte SA
    Curr Opin Drug Discov Devel; 2005 Sep; 8(5):585-9. PubMed ID: 16159020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refining efficacy: allosterism and bias in G protein-coupled receptor signaling.
    Luttrell LM; Kenakin TP
    Methods Mol Biol; 2011; 756():3-35. PubMed ID: 21870218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational complexity of G-protein-coupled receptors.
    Kobilka BK; Deupi X
    Trends Pharmacol Sci; 2007 Aug; 28(8):397-406. PubMed ID: 17629961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Light- and drug-activated G-protein-coupled receptors to control intracellular signalling.
    Masseck OA; Rubelowski JM; Spoida K; Herlitze S
    Exp Physiol; 2011 Jan; 96(1):51-6. PubMed ID: 21041315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [G-protein-coupled receptors targeting: the allosteric approach].
    Sebag JA; Pantel J
    Med Sci (Paris); 2012 Oct; 28(10):845-51. PubMed ID: 23067415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New concepts in drug discovery: collateral efficacy and permissive antagonism.
    Kenakin T
    Nat Rev Drug Discov; 2005 Nov; 4(11):919-27. PubMed ID: 16264435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane signalling complexes: implications for development of functionally selective ligands modulating heptahelical receptor signalling.
    Piñeyro G
    Cell Signal; 2009 Feb; 21(2):179-85. PubMed ID: 18790047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inverse agonism: more than reverting constitutively active receptor signaling.
    Dupré DJ; Rola-Pleszczynski M; Stanková J
    Biochem Cell Biol; 2004 Dec; 82(6):676-80. PubMed ID: 15674435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fulfilling the Promise of "Biased" G Protein-Coupled Receptor Agonism.
    Luttrell LM; Maudsley S; Bohn LM
    Mol Pharmacol; 2015 Sep; 88(3):579-88. PubMed ID: 26134495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.